Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function - PubMed (original) (raw)

. 1995 Jun 1;55(11):2448-54.

Affiliations

PMID: 7757999

Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function

C Singer et al. Cancer Res. 1995.

Abstract

Paracrine interactions between stromal and epithelial cells are important influences on the growth and malignant behavior of breast cancers. Insulin-like growth factors I and II (IGF-I and II) are expressed by fibroblasts in benign and malignant breast lesions, and both are strong mitogens for a number of breast cancer epithelial cell lines in vitro. We have analyzed the stromal mRNA expression of IGF-I and IGF-II in matched sets of fibroblast cell lines derived from three locations in the affected breast of eight patients with breast cancer: (a) the breast tumor itself; (b) surrounding normal breast tissue; and (c) overlying breast skin. IGF-I expression was easily detected in all fibroblasts derived from normal breast tissue. In general, lesser amounts of IGF-I mRNA were detected in fibroblasts derived from breast tumors or skin. In contrast, IGF-II expression was detected at very low levels in only 3 of 8 normal breast fibroblasts, but was present in 6 of 8 tumor fibroblasts. IGF-II mRNA was expressed in all skin fibroblasts tested. IGF-II-negative stromal fibroblasts from normal breast, which were plated at low density and allowed to grow to confluence in the presence of MCF-7 breast tumor epithelial cells, demonstrated a marked increase in IGF-II mRNA expression. IGF-II in situ hybridization studies confirmed that IGF-II expression is seen at high levels in stroma of many invasive breast cancers but not normal breast. We conclude that paracrine influences, mediated by soluble factors released by breast tumor epithelium, are able to specifically increase expression of IGF-II in breast stroma, most likely by a process of clonal selection.

PubMed Disclaimer

Cited by

Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity.
Shekhar MP, Santner S, Carolin KA, Tait L. Shekhar MP, et al. Am J Pathol. 2007 May;170(5):1546-60. doi: 10.2353/ajpath.2007.061004. Am J Pathol. 2007. PMID: 17456761 Free PMC article.
Functional and gene network analyses of transcriptional signatures characterizing pre-weaned bovine mammary parenchyma or fat pad uncovered novel inter-tissue signaling networks during development.
Piantoni P, Bionaz M, Graugnard DE, Daniels KM, Everts RE, Rodriguez-Zas SL, Lewin HA, Hurley HL, Akers M, Loor JJ. Piantoni P, et al. BMC Genomics. 2010 May 26;11:331. doi: 10.1186/1471-2164-11-331. BMC Genomics. 2010. PMID: 20504330 Free PMC article.
Expression of keratinocyte growth factor and its receptor in human breast cancer.
Bansal GS, Cox HC, Marsh S, Gomm JJ, Yiangou C, Luqmani Y, Coombes RC, Johnston CL. Bansal GS, et al. Br J Cancer. 1997;75(11):1567-74. doi: 10.1038/bjc.1997.269. Br J Cancer. 1997. PMID: 9184170 Free PMC article.
Seed in soil, with an epigenetic view.
Lin HJ, Zuo T, Chao JR, Peng Z, Asamoto LK, Yamashita SS, Huang TH. Lin HJ, et al. Biochim Biophys Acta. 2009 Sep;1790(9):920-4. doi: 10.1016/j.bbagen.2008.12.004. Epub 2008 Dec 30. Biochim Biophys Acta. 2009. PMID: 19162126 Free PMC article. Review.
Positive regulation of normal and tumoral mammary epithelial cell proliferation by fibroblasts in coculture.
Gache C, Berthois Y, Martin PM, Saez S. Gache C, et al. In Vitro Cell Dev Biol Anim. 1998 Apr;34(4):347-51. doi: 10.1007/s11626-998-0012-2. In Vitro Cell Dev Biol Anim. 1998. PMID: 9590509

Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function - PubMed (original) (raw)